Ayhan Ulusakarya

1.1k total citations
45 papers, 792 citations indexed

About

Ayhan Ulusakarya is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Ayhan Ulusakarya has authored 45 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Hepatology. Recurrent topics in Ayhan Ulusakarya's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer survivorship and care (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Ayhan Ulusakarya is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer survivorship and care (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Ayhan Ulusakarya collaborates with scholars based in France, United Kingdom and United States. Ayhan Ulusakarya's co-authors include Pasquale F. Innominato, Oxana Palesh, Françis Lévi, David Spiegel, Véronique Roche, Georg A. Bjarnason, Sylvie Giacchetti, Mohamed Bouchahda, Abdoulaye Karaboué and Lucile Capuron and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ayhan Ulusakarya

41 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ayhan Ulusakarya France	16	304	226	201	170	119	45	792
Pascal Bleuzen France	7	254 0.8×	219 1.0×	127 0.6×	71 0.4×	122 1.0×	10	636
Lára G. Sigurðardóttir Iceland	12	111 0.4×	257 1.1×	166 0.8×	67 0.4×	134 1.1×	15	751
Susana Hernández Spain	10	111 0.4×	97 0.4×	63 0.3×	111 0.7×	49 0.4×	20	754
Pei Xue China	17	259 0.9×	77 0.3×	105 0.5×	220 1.3×	85 0.7×	74	1.3k
Nancie Petrucelli United States	14	251 0.8×	38 0.2×	100 0.5×	65 0.4×	49 0.4×	24	1.3k
Delilah Zabaneh United Kingdom	14	75 0.2×	146 0.6×	97 0.5×	18 0.1×	159 1.3×	20	1.4k
Yinin Hu United States	19	316 1.0×	375 1.7×	29 0.1×	318 1.9×	191 1.6×	81	1.5k
Ruchi Sharma United States	9	246 0.8×	44 0.2×	26 0.1×	91 0.5×	94 0.8×	23	806
Chih‐Teng Yu Taiwan	14	256 0.8×	16 0.1×	74 0.4×	195 1.1×	23 0.2×	32	536
Jocelyn Sendecki United States	19	448 1.5×	69 0.3×	12 0.1×	196 1.2×	59 0.5×	35	1.2k

Countries citing papers authored by Ayhan Ulusakarya

Since Specialization

Citations

This map shows the geographic impact of Ayhan Ulusakarya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayhan Ulusakarya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayhan Ulusakarya more than expected).

Fields of papers citing papers by Ayhan Ulusakarya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayhan Ulusakarya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayhan Ulusakarya. The network helps show where Ayhan Ulusakarya may publish in the future.

Co-authorship network of co-authors of Ayhan Ulusakarya

This figure shows the co-authorship network connecting the top 25 collaborators of Ayhan Ulusakarya. A scholar is included among the top collaborators of Ayhan Ulusakarya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayhan Ulusakarya. Ayhan Ulusakarya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boilève, Alice, Franck Audemar, Samuel Le Sourd, et al.. (2025). Treatment Intensification with Hepatic Arterial Infusion Chemotherapy in Patients with Liver-Only Colorectal Metastases Still Unresectable After Systemic Induction Chemotherapy: Exploratory Findings From a Prematurely Closed Multicenter Randomized Phase II Study: SULTAN UCGI 30/PRODIGE 53 (NCT03164655). Annals of Surgical Oncology. 33(2). 1460–1469.

Legros, Laurence, Catherine Guettier, Emma Goldschmidt, et al.. (2023). Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 91(4). 337–344. 6 indexed citations

Bouchahda, Mohamed, Ayhan Ulusakarya, Anne Thirot‐Bidault, et al.. (2023). Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948). BMJ Open. 13(6). e069973–e069973. 1 indexed citations

Ulusakarya, Ayhan, et al.. (2021). Anti‐Programmed death‐1 therapy in advanced hepatocellular carcinoma: A real‐world experience. SHILAP Revista de lepidopterología. 9(4). 2162–2167. 2 indexed citations

Innominato, Pasquale F., Sandra Komarzynski, Robert Dallmann, et al.. (2021). Impact of assessment frequency of patient-reported outcomes: an observational study using an eHealth platform in cancer patients. Supportive Care in Cancer. 29(11). 6167–6170. 9 indexed citations

Ulusakarya, Ayhan, Abdoulaye Karaboué, Oriana Ciacio, et al.. (2020). A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer. BMC Cancer. 20(1). 515–515. 11 indexed citations

Boilève, Alice, Aline Maillard, Mathilde Wagner, et al.. (2020). Treatment intensification with hepatic arterial infusion chemotherapy in patients with liver-only colorectal metastases still unresectable after systemic induction chemotherapy – a randomized phase II study -- SULTAN UCGI 30/PRODIGE 53 (NCT03164655)- study protocol. BMC Cancer. 20(1). 74–74. 12 indexed citations

Komarzynski, Sandra, Qi Huang, Pasquale F. Innominato, et al.. (2018). Relevance of a Mobile Internet Platform for Capturing Inter- and Intrasubject Variabilities in Circadian Coordination During Daily Routine: Pilot Study. Journal of Medical Internet Research. 20(6). e204–e204. 21 indexed citations

Palesh, Oxana, Françis Lévi, Georg A. Bjarnason, et al.. (2017). Relationship between subjective and actigraphy-measured sleep in 237 patients with metastatic colorectal cancer. Quality of Life Research. 26(10). 2783–2791. 31 indexed citations

10.

Innominato, Pasquale F., Sandra Komarzynski, Ali Mohammad‐Djafari, et al.. (2016). Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project. Journal of Medical Internet Research. 18(11). e305–e305. 23 indexed citations

11.

Innominato, Pasquale F., David Spiegel, Ayhan Ulusakarya, et al.. (2015). Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer. Sleep Medicine. 16(3). 391–398. 61 indexed citations

12.

Innominato, Pasquale F., Véronique Roche, Oxana Palesh, et al.. (2014). The circadian timing system in clinical oncology. Annals of Medicine. 46(4). 191–207. 145 indexed citations

13.

Ulusakarya, Ayhan, et al.. (2009). Acute renal failure related to oxaliplatin-induced intravascular hemolysis. Medical Oncology. 27(4). 1425–1426. 23 indexed citations

14.

Machover, D., Béatrice Delmas-Marsalet, Ayhan Ulusakarya, et al.. (2009). Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma. Biomedicine & Pharmacotherapy. 64(2). 83–87. 5 indexed citations

15.

Ulusakarya, Ayhan, Sophie Gad, Mathilde Sibony, et al.. (2007). Novel somatic mutations of the VHL gene in an erythropoietin‐producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells. American Journal of Hematology. 83(2). 155–158. 9 indexed citations

16.

Ulusakarya, Ayhan, et al.. (2006). Blepharitis Induced by Epidermal Growth Factor Receptor-Targeting Therapy. American Journal of Clinical Oncology. 29(5). 531–531. 1 indexed citations

17.

Bourhis, J-H, JL Pico, Ayhan Ulusakarya, et al.. (2001). Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy. Bone Marrow Transplantation. 27(5). 531–536. 14 indexed citations

18.

Machover, D., Béatrice Delmas-Marsalet, Emma Goldschmidt, et al.. (2001). Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin’s lymphoma. Annals of Oncology. 12(10). 1439–1443. 37 indexed citations

19.

Ulusakarya, Ayhan, Philippe Terrier, Jean‐François Régnard, Vincent de Montpréville, & Jean‐Nicolas Munck. (1999). Extraskeletal Osteosarcoma of the Mediastinum After Treatment of a Mediastinal Germ-Cell Tumor. American Journal of Clinical Oncology. 22(6). 609–609. 12 indexed citations

20.

Ulusakarya, Ayhan, J. Lumbroso, Odile Casiraghi, et al.. (1999). Gallium Scan in the Evaluation of Post Chemotherapy Mediastinal Residual Masses of Aggressive Non-Hodgkin's Lymphoma. Leukemia & lymphoma. 35(5-6). 579–586. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact